From June 5 to 7, the 20th China Hospital President Annual Meeting, hosted by China Hospital Director magazine and China Hospital Director Network, was grandly held in Xiamen. At this pivotal juncture marking the launch of the 15th Five-Year Plan, the meeting convened under the theme “Navigating the New Cycle,” bringing together hospital administrators, experts, scholars, and industry peers from across the country to fulfill a remarkable “20-Year Promise” and explore pathways to high-quality development amid structural transformation.

At this event—widely regarded as the bellwether of China’s hospital management development—Edge Medical®, as a dedicated developer of China’s independently manufactured high-end medical equipment, made a landmark appearance with the world’s first “3-in-1” surgical robot platform integrating multi-port, single-port, and tele-surgery capabilities, alongside China’s first dual-arm bronchoscopy robot. Together, these innovations demonstrated how “Made in China” is leveraging disruptive innovation to empower hospital administrators in achieving cost efficiency and breakthrough innovation in the “new cycle.”

Anchoring the “New Cycle”: Surgical Robots as the “New Productive Force” for High-Quality Development

This year’s meeting prominently featured discussions around “structural transformation,” “value-based healthcare,” and “digital transformation.” As healthcare payment reform deepens, population aging accelerates, and the public’s demand for high-quality medical services intensifies, hospital administrators are seeking a “new productive force”—one that safeguards medical safety and quality while enhancing operational efficiency and reducing overall costs.

Edge Medical offers a precise response to this defining challenge. The “3-in-1” surgical robot platform showcased at the meeting is not a simple stacking of features; it is a fundamental reconstruction of the underlying architecture. Its core value ultimately returns to the essence of medicine—serving clinical practice, benefiting patients, and empowering hospitals.

Edge “3-in-1” Disruptive Innovation: One System Covering All Scenarios

The Edge “3-in-1” surgical robot platform achieves a globally pioneering design—“one system, multi-procedure compatibility, seamless switching between local and remote surgery”—truly realizing “one platform, multiple capabilities” to meet the full spectrum of minimally invasive surgical needs.

Three Core Functions, One Integrated Solution

The platform completely breaks through the single-function limitations of traditional surgical robots:

• Multi-Port Robot: Focused on high-difficulty, complex laparoscopic surgeries, it delivers the stability and precision needed to tackle the most challenging cases—serving as the “ballast stone” that safeguards the quality of care for critical and severe conditions.

• Single-Port Robot: Designed with the goal of “less trauma, faster recovery,” it meets the demand for refined minimally invasive procedures—representing both a technological advancement and an expression of humanistic care.

• Tele-Surgery: Enables high-quality medical resources to transcend geography, radiating in real time from central cities to grassroots hospitals. This provides a practical technological pathway to address the long-standing challenge of unequal distribution of medical resources in China.

All three core modules share a unified underlying technology platform, synergistically covering the full range of scenarios: complex minimally invasive surgery, ultra-minimally invasive diagnosis and treatment, and cross-regional medical collaboration.

Three Dimensions of Value, Returning to the Essence of Medicine

• For Patients: Personalized surgical plans tailored to each condition, achieving ultra-minimally invasive access while accelerating recovery—embedding the “patient-centered” philosophy into every single procedure.

• For Surgeons: One system simultaneously meets the stability demands of daily multi-port procedures and supports research and clinical adoption of cutting-edge single-port and tele-surgery technologies—providing clinicians with broader research directions and more powerful clinical tools, advancing both discipline development and professional growth.

• For Hospitals: The strategic value of “one platform, multiple capabilities” is achieved through a more streamlined investment—aligning with the management imperative of “cost efficiency” while providing a solid technological foundation for hospitals to elevate their minimally invasive surgery disciplines to new heights.

This systematic, end-to-end clinical service layout helps hospitals achieve an “intrinsic leap” in both technical capability and service quality under more concentrated resource investment—giving hospital administrators greater confidence and composure as they drive the transition from scale expansion to quality-driven growth.

China’s First Dual-Arm Bronchoscopy Robot: Opening New Scenarios for Non-Invasive Diagnosis and Treatment

At this year’s meeting, another innovative product from Edge Medical also drew significant attention: CP1000, China’s first dual-arm bronchoscopy robot.

As a fully flexible bronchoscopy robot designed specifically for respiratory interventional diagnosis and treatment, CP1000 integrates high-precision robotic arms, an intelligent navigation system, and an intuitive visualization interface. It overcomes long-standing pain points of traditional bronchoscopy—insufficient operational precision and steep learning curves—making more precise, minimally invasive, and convenient bronchoscopic procedures a reality.

This product offers a new domestically developed solution for early-stage lung cancer diagnosis and complex airway disease treatment. It is a proactive response to the meeting’s strategic direction of “centered on health”—early detection, early diagnosis, and early treatment represent the critical shift from “treating disease” to “safeguarding health.”

From minimally invasive to non-invasive, Edge Medical is building an increasingly complete domestic surgical robot ecosystem—continuously expanding the boundaries of technology and redefining the value proposition of surgical robots.

Four Consecutive Appearances at the Annual Meeting: Charting a New Future of Hospital-Enterprise Collaboration

Since its inaugural session, the China Hospital President Annual Meeting has journeyed alongside the industry for two decades, making an indelible contribution to advancing the high-quality development of China’s healthcare sector.

As the first company in China and the second globally to obtain regulatory approvals for multi-port, single-port laparoscopic surgical robots, and natural orifice surgical robots, Edge Medical has appeared at the China Hospital President Annual Meeting for four consecutive years. Its booth has consistently drawn large crowds, with numerous attending presidents and department heads visiting for in-depth discussions and hands-on trial sessions, while industry media have also covered the exhibit extensively.

Multiple hospital administrators noted that the integrated design philosophy of the Edge “3-in-1” platform enables hospitals to maximize technical output within limited physical space and budgets. Domestic high-end medical device enterprises like Edge Medical are not merely equipment providers—they are collaborative innovation partners on hospitals’ path toward high-quality development.

Standing at the new starting point of the 15th Five-Year Plan, Edge Medical will continue to uphold its founding mission, leveraging more forward-looking “China Solutions” to help hospital administrators navigate through cyclical uncertainty, find their strategic positioning amid transformation, and jointly write a new chapter of enduring excellence for China’s healthcare sector.